Blueteq

BSW Inflammatory Bowel Disease Pathways

Adalimumab Imraldi Amgevita Humira Infliximab Remsima Inflectra Remicade Golimumab Simponi ustekinumab Stelara vedolizumab Entyvio Tofacitinib Xeljanz Ulcerative colitis crohn’s disease crohns TDM IBD

Blueteq Ophthalmology Pathway

DMO CRVO BVRO CNV choroidal nevascularisation aflibercept Eylea ranibizumab Lucentis AMD Dexamethasone Fluocinolone brolucizumab Beovu

BSW PCSK9 Pathway

  • by

primary hypercholesterolaemia mixed dyslipidaemia Alirocumab Praluent Evolocumab Repatha cholesterol